Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Does long-term albumin therapy prolong survival in cirrhotic patients?

18 May 2025 bởi

Long-term human albumin (LTA) therapy among cirrhotic patients with existing or prior ascites and acute decompensation results in improved transplant-free survival (TFS), mortality, and disease-related complications, according to the results of the PRECIOSA trial.

Does long-term albumin therapy prolong survival in cirrhotic patients?

18 May 2025

Stimulant use not causally associated with psychotic experiences

18 May 2025

There is no evidence to support a causal link between stimulant prescriptions and psychotic experiences, according to a study.

Stimulant use not causally associated with psychotic experiences

18 May 2025

Neoadjuvant therapy extends survival in left-sided resectable pancreatic cancer

17 May 2025

Patients with left-sided resectable pancreatic cancer (RPC) enjoy improved overall survival (OS) with neoadjuvant therapy compared with upfront surgery, a recent study has shown.

Neoadjuvant therapy extends survival in left-sided resectable pancreatic cancer

17 May 2025

Novel agent lowers LDL-C in ASCVD at-risk patients

16 May 2025

Inhibition of angiopoietin-like 3 (ANGPTL-3) with SHR-1918 leads to further low-density lipoprotein cholesterol (LDL-C) reductions in patients at increased risk of atherosclerotic cardiovascular disease (ASCVD), a phase II study has shown.

Novel agent lowers LDL-C in ASCVD at-risk patients

16 May 2025

Temocillin a good alternative to carbapenems for bacteraemia

16 May 2025 bởi

The use of temocillin demonstrates comparable efficacy and safety to carbapenems for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (3GCR-E), primarily from urinary sources, reports a study.

Temocillin a good alternative to carbapenems for bacteraemia

16 May 2025

5-day antibiotic use viable in CAP patients with clinical stability

16 May 2025 bởi

Antibiotic treatment may be done for 5 days, as opposed to at least 7 days, in hospitalized patients with community-acquired pneumonia (CAP) who had achieved clinical stability by day 3 to 5, suggests a study presented at ESCMID Global 2025.

5-day antibiotic use viable in CAP patients with clinical stability

16 May 2025

Updated EPIC-HR data bolster nirmatrelvir/ritonavir role against COVID-19

16 May 2025 bởi

Updated data from the EPIC-HR* trial show reduced duration of COVID-19 symptoms and utilization of healthcare resources with nirmatrelvir/ritonavir (NMV/r) in high-risk, unvaccinated, nonhospitalized, symptomatic adults with COVID-19.

Updated EPIC-HR data bolster nirmatrelvir/ritonavir role against COVID-19

16 May 2025

Linaclotide improves bowel symptoms in children with functional constipation

16 May 2025 bởi

Treatment with linaclotide led to significantly improved symptoms of incomplete bowel evacuation and straining in paediatric patients aged 6–17 years with functional constipation, according to a phase III study presented at DDW 2025.

Linaclotide improves bowel symptoms in children with functional constipation

16 May 2025

Starting DOACs sooner after stroke may be best for AF patients

15 May 2025 bởi

For secondary stroke prevention in patients with atrial fibrillation (AF), the optimal timing of initiating a direct oral anticoagulant (DOAC) remains elusive, although evidence from a phase II study suggests that earlier initiation is better than later times within the first 2 weeks after stroke onset.

Starting DOACs sooner after stroke may be best for AF patients

15 May 2025

Tirzepatide eases MetS, cardiometabolic abnormalities in T2D

15 May 2025

Individuals with type 2 diabetes (T2D) may benefit from using tirzepatide, which has been shown in a recent study to improve cardiometabolic abnormalities and resolve metabolic syndrome (MetS).

Tirzepatide eases MetS, cardiometabolic abnormalities in T2D

15 May 2025

Tin tức & Cập nhật

Xem bài viết Dược

Xem

Chuyên ngành:

Does long-term albumin therapy prolong survival in cirrhotic patients?

Does long-term albumin therapy prolong survival in cirrhotic patients?

Stimulant use not causally associated with psychotic experiences

Stimulant use not causally associated with psychotic experiences

Neoadjuvant therapy extends survival in left-sided resectable pancreatic cancer

Neoadjuvant therapy extends survival in left-sided resectable pancreatic cancer

Novel agent lowers LDL-C in ASCVD at-risk patients

Novel agent lowers LDL-C in ASCVD at-risk patients

Temocillin a good alternative to carbapenems for bacteraemia

Temocillin a good alternative to carbapenems for bacteraemia

5-day antibiotic use viable in CAP patients with clinical stability

5-day antibiotic use viable in CAP patients with clinical stability

Updated EPIC-HR data bolster nirmatrelvir/ritonavir role against COVID-19

Updated EPIC-HR data bolster nirmatrelvir/ritonavir role against COVID-19

Linaclotide improves bowel symptoms in children with functional constipation

Linaclotide improves bowel symptoms in children with functional constipation

Starting DOACs sooner after stroke may be best for AF patients

Starting DOACs sooner after stroke may be best for AF patients

Tirzepatide eases MetS, cardiometabolic abnormalities in T2D

Tirzepatide eases MetS, cardiometabolic abnormalities in T2D